| Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes B Tavira, EC Garciá, C Díaz-Corte, F Ortega, M Arias, A Torres, JM Díaz, ... Clinical chemistry and laboratory medicine 49 (5), 825-833, 2011 | 72 | 2011 |
| Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes L Åkerman, R Casas, J Ludvigsson, B Tavira, C Skoglund PLoS One 13 (1), e0191067, 2018 | 65 | 2018 |
| Chronic kidney disease-mineral and bone disorder: a complex scenario N Mejia, N Mejía, P Roman-Garcia, P Roman-García, AB Miar, AB Miar, ... Nefrología (English Edition) 31 (5), 514-519, 2011 | 63 | 2011 |
| A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients B Tavira, E Coto, C Diaz-Corte, V Alvarez, C López-Larrea, F Ortega Pharmacogenetics and Genomics 23 (8), 445-448, 2013 | 59 | 2013 |
| Pharmacogenetics of calcineurin inhibitors in renal transplantation E Coto, B Tavira Transplantation 88 (3S), S62-S67, 2009 | 59 | 2009 |
| Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis S Ortiz-Espinosa, X Morales, Y Senent, D Alignani, B Tavira, I Macaya, ... Cancer letters 529, 70-84, 2022 | 58 | 2022 |
| Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation B Diaz-Molina, B Tavira, JL Lambert, MJ Bernardo, V Alvarez, E Coto Transplantation proceedings 44 (9), 2635-2638, 2012 | 41 | 2012 |
| KCNQ1 gene variants and risk of new‐onset diabetes in tacrolimus‐treated renal‐transplanted patients B Tavira, E Coto, C Díaz‐Corte, F Ortega, M Arias, A Torres, JM Díaz, ... Clinical transplantation 25 (3), E284-E291, 2011 | 41 | 2011 |
| Association between a common KCNJ11 polymorphism (rs5219) and new-onset posttransplant diabetes in patients treated with Tacrolimus B Tavira, E Coto, A Torres, C Díaz-Corte, B Díaz-Molina, F Ortega, M Arias, ... Molecular Genetics and metabolism 105 (3), 525-527, 2012 | 37 | 2012 |
| Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier E Coto, M Palacín, M Martín, MG Castro, JR Reguero, C García, ... Journal of translational medicine 8, 1-9, 2010 | 33 | 2010 |
| The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients B Tavira, J Gómez, C Díaz-Corte, D Coronel, C Lopez-Larrea, B Suarez, ... Journal of human genetics 60 (5), 273-276, 2015 | 32 | 2015 |
| Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort B Tavira, E Coto, J Gómez, S Tranche, K Miguélez, F Ortega, B Díez, ... Gene 520 (1), 73-76, 2013 | 31 | 2013 |
| Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients B Tavira, J Gómez, C Díaz-Corte, L LLobet, E Ruiz-Pesini, F Ortega, ... Gene 538 (1), 195-198, 2014 | 30 | 2014 |
| Resequencing the whole MYH7 gene (including the intronic, promoter, and 3′ UTR sequences) in hypertrophic cardiomyopathy E Coto, JR Reguero, M Palacín, J Gómez, B Alonso, S Iglesias, M Martín, ... The Journal of Molecular Diagnostics 14 (5), 518-524, 2012 | 29 | 2012 |
| Intralymphatic glutamic acid decarboxylase‐alum administration induced Th2‐like‐specific immunomodulation in responder patients: a pilot clinical trial in type 1 diabetes B Tavira, H Barcenilla, J Wahlberg, P Achenbach, J Ludvigsson, R Casas Journal of Diabetes Research 2018 (1), 9391845, 2018 | 25 | 2018 |
| Glutamic acid decarboxylase injection into lymph nodes: beta cell function and immune responses in recent onset type 1 diabetes patients R Casas, F Dietrich, H Barcenilla, B Tavira, J Wahlberg, P Achenbach, ... Frontiers in Immunology 11, 564921, 2020 | 24 | 2020 |
| A labor-and cost-effective non-optical semiconductor (Ion Torrent) next-generation sequencing of the SLC12A3 and CLCNKA/B genes in Gitelman’s syndrome patients B Tavira, J Gómez, F Santos, H Gil, V Alvarez, E Coto Journal of human genetics 59 (7), 376-380, 2014 | 23 | 2014 |
| Effect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort E Coto, B Tavira, J Gómez, S Tranche, C Díaz Corte Cardiorenal medicine 4 (2), 82-87, 2014 | 23 | 2014 |
| Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy E Coto, B Tavira, R Marín, F Ortega, C López-Larrea, M Ruiz-Ortega, ... Biochemical and biophysical research communications 397 (3), 576-579, 2010 | 23 | 2010 |
| Pharmacogenetics of tacrolimus: ready for clinical translation? E Coto, B Tavira, B Suárez-Álvarez, C López-Larrea, C Díaz-Corte, ... Kidney international supplements 1 (2), 58-62, 2011 | 17 | 2011 |
